Overview

A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen
Phase:
Phase 1
Details
Lead Sponsor:
Sunovion
Treatments:
Contraceptive Agents
Contraceptives, Oral
Fluoroquinolones
Lurasidone Hydrochloride
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination